New Market Study Published: Neurotrek, Inc. - Product Pipeline Analysis
Neurotrek, Inc. (Neurotrek) is a biotechnology company. It focuses on the development of U+, a targeted, non-invasive neuromodulation technology. U+ is a proprietary platform that uses ultrasound to modulate brain tissue or nerve tissue in a targeted, non-invasive manner via patterned vibrations. The technology finds application in various areas such as, epilepsy, pain, depression and mood disorder, diagnostic brain mapping, and cognitive abilities and communication. The company's U+ is currently in pre-clinical, early-stage development stage. Neurotrek is headquartered in Los...
View full press release